WallStreetZenWallStreetZen

NASDAQ: ENGN
Engene Holdings Inc Stock Forecast, Predictions & Price Target

Analyst price target for ENGN

Based on 5 analysts offering 12 month price targets for Engene Holdings Inc.
Min Forecast
$30.00+91.08%
Avg Forecast
$34.40+119.11%
Max Forecast
$40.00+154.78%

Should I buy or sell ENGN stock?

Based on 5 analysts offering ratings for Engene Holdings Inc.
Strong Buy
Strong Buy
4 analysts 80%
Buy
1 analysts 20%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ENGN stock forecasts and price targets.

ENGN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-22
lockedlocked$00.00+00.00%2024-04-15
lockedlocked$00.00+00.00%2024-03-28
lockedlocked$00.00+00.00%2024-03-08
lockedlocked$00.00+00.00%2024-02-20

1 of 1

Forecast return on equity

Is ENGN forecast to generate an efficient return?
Insufficient data to display

Forecast return on assets

Is ENGN forecast to generate an efficient return on assets?
Insufficient data to display

ENGN revenue forecast

What is ENGN's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$41.3M
Avg 2 year Forecast
$130.7M
Avg 3 year Forecast
$245.7M

ENGN vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ENGN$15.70$34.40+119.11%Strong Buy
YMAB$15.50$24.33+56.99%Strong Buy
COGT$6.71$13.67+103.68%Buy
IRON$28.29$69.60+146.02%Buy
PHAR$9.91$37.00+273.36%Buy

Engene Holdings Stock Forecast FAQ

Is Engene Holdings Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NASDAQ: ENGN) stock is to Strong Buy ENGN stock.

Out of 5 analysts, 4 (80%) are recommending ENGN as a Strong Buy, 1 (20%) are recommending ENGN as a Buy, 0 (0%) are recommending ENGN as a Hold, 0 (0%) are recommending ENGN as a Sell, and 0 (0%) are recommending ENGN as a Strong Sell.

If you're new to stock investing, here's how to buy Engene Holdings stock.

What is ENGN's revenue growth forecast for 2026-2028?

(NASDAQ: ENGN) Engene Holdings's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.46%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.97%.

Engene Holdings's revenue in 2024 is N/A.On average, 1 Wall Street analysts forecast ENGN's revenue for 2026 to be $1,798,601,530, with the lowest ENGN revenue forecast at $1,798,601,530, and the highest ENGN revenue forecast at $1,798,601,530. On average, 1 Wall Street analysts forecast ENGN's revenue for 2027 to be $5,696,951,588, with the lowest ENGN revenue forecast at $5,696,951,588, and the highest ENGN revenue forecast at $5,696,951,588.

In 2028, ENGN is forecast to generate $10,708,804,653 in revenue, with the lowest revenue forecast at $10,708,804,653 and the highest revenue forecast at $10,708,804,653.

What is ENGN's forecast return on assets (ROA) for 2026-2027?

(NASDAQ: ENGN) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is ENGN's Price Target?

According to 5 Wall Street analysts that have issued a 1 year ENGN price target, the average ENGN price target is $34.40, with the highest ENGN stock price forecast at $40.00 and the lowest ENGN stock price forecast at $30.00.

On average, Wall Street analysts predict that Engene Holdings's share price could reach $34.40 by Apr 22, 2025. The average Engene Holdings stock price prediction forecasts a potential upside of 119.11% from the current ENGN share price of $15.70.

What is ENGN's forecast return on equity (ROE) for 2026-2027?

(NASDAQ: ENGN) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.